Popular Articles

Researcher Awarded $1.6 Million To Investigate Tumor Suppressor's Role In Breast Cancer
Studies have estimated that five to

Xeloda In Combination With Oxaliplatin Shown To Be Effective In Early Colon Cancer
Roche announced results from the international phase III study NO16968 (XELOXA), investigating oral Xeloda in combination with intravenous oxaliplatin (XELOX) immediately after surgery, which show that patients with colon cancer taking XELOX live disease free for longer compared to those taking the commonly used intravenous chemotherapy combination 5-fluorouracil/leucovorin (5-FU/LV). The data prove that XELOX is superior to 5-FU/LV in terms of the time patients live without their cancer being detectable.
News of the day
New Figures Reveal Ethnic Minorities Are Not Aware Of Their Cancer Risk
Despite growing evidence that cancer is becoming more prevalent amongst ethnic minority groups, news figures out today at the start of Ethnic Minority Cancer Awareness Week show that cancer awareness levels are critically low amongst this cohort.
Oncology

Puberty In Offspring Delayed By Postpartum Anxiety

Hormonal changes early in pregnancy cause maternal postpartum anxiety and behavior changes that can lead to a delayed onset of puberty in both birth and adoptive daughters, according to a new study conducted in mice. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C. Women have an increased rate of anxiety during pregnancy and for 2 years after giving birth, said the study"s lead author, Caroline Larsen, PhD, a postdoctoral fellow at the University of Otago in Dunedin, New Zealand. "Postpartum anxiety disorders are poorly understood and difficult to treat," Larsen said. "There is growing evidence that untreated anxiety disorder during pregnancy may contribute to premature birth and also can have major and lasting adverse effects on the infant"s development and behavior." Prolactin is a hormone that may protect against anxiety. Recently Larsen and her co-workers found that mice with induced low levels of prolactin in early pregnancy displayed substantial anxiety after they gave birth. Because the researchers also noted that daughters of the anxious mothers had delayed onset of puberty, they conducted the current study to learn what causes this late physical transition to sexual maturation. Daughters of female mice made anxious by low prolactin were raised either by their birth mother or by a mouse who was not anxious (control mother). Another group consisted of daughters of nonanxious mice, and these mice were raised by either a control mother or an anxious mother. There were at least six mice in each of the four groups. The researchers determined onset of puberty by examining when the vagina opened and noting the time of first estrus (equivalent to the first menstrual cycle in humans). "Remarkably, puberty was still delayed even if the daughters of anxious mothers were raised by nonanxious mice," Larsen said. "And delayed puberty also occurred in daughters born to nonanxious mothers who were raised by anxious mothers." This result demonstrates that hormonal changes in early pregnancy, as well as changes in maternal behavior caused by these hormone changes, can alter brain development in the offspring and delay puberty, she explained. Larsen believes that their work, with further study, may translate to people. "Finding the hormonal mechanisms that trigger the timing of puberty in mice may help identify potential targets for the prevention and treatment of delayed or early puberty in humans," she said. Late puberty in humans is linked to shortened height and psychological problems that can persist into adulthood. The University of Otago helped fund this study, as did a grant from the New Zealand Lottery Foundation. Aaron Lohr The Endocrine Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):